Publication Name	World Journal of Gastroenterology
Manuscript ID	5586
Country	Italy

Received	2013-09-16 10:50
Peer-Review Started	2013-09-16 14:53
To Make the First Decision	2013-09-27 16:29
Return for Revision	2013-09-30 11:59
Revised	2013-10-03 04:28
Second Decision	2013-11-04 18:08
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2013-11-05 10:42
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor	2013-11-14 22:03
Typeset the Manuscript	2014-01-22 09:46
Publish the Manuscript Online	2014-03-12 11:24

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Nutrition & Dietetics
Manuscript Type	Topic Highlights
Article Title	Modulation of hepatic steatosis by dietary fatty acids
Manuscript Source	Invited Manuscript
All Author List	Alessandra Ferramosca and Vincenzo Zara
Funding Agency and Grant Number
Corresponding Author	Vincenzo Zara, Professor, Dipartimento di Scienze e Tecnologie Biologiche ed Ambientali, Università del Salento, Via Provinciale Lecce-Monteroni, I-73100 Lecce, Italy. vincenzo.zara@unisalento.it
Key Words	Hepatic steatosis; Non-alcoholic fatty liver; Fatty acids; Lipogenesis
Core Tip	Dietary fats may not only influence the pathogenesis of liver diseases, but may also prevent and/or reverse their expression. This manuscript reviews the molecular mechanisms responsible for the regulation of hepatic lipogenesis, through which some fatty acids may be beneficial or detrimental to non-alcoholic fatty liver disease (NAFLD). We believe that an understanding of the biochemical mechanisms underlying fat accumulation in the liver will lead to more targeted and effective therapeutics for hepatic steatosis. This is a particularly important topic because NAFLD is an increasingly prevalent disease which, to date, has no proven pharmacologic treatment to prevent or reverse its course.
Publish Date	2014-03-12 11:24
Citation	Ferramosca A, Zara V. Modulation of hepatic steatosis by dietary fatty acids. World J Gastroenterol 2014; 20(7): 1746-1755
URL	http://www.wjgnet.com/1007-9327/full/v20/i7/1746.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i7.1746

Full Article (PDF)	WJG-20-1746.pdf
Full Article (Word)	WJG-20-1746.doc
Manuscript File	5586-Review.doc
Answering Reviewers	5586-Answering reviewers.pdf
Copyright License Agreement	5586-Copyright assignment.pdf
Peer-review Report	5586-Peer reviewer(s).pdf
Scientific Editor Work List	5586-Scientific editor work list.doc